Author

Dominic Devost

McGill UniversityORCID 0000-0001-5278-1062Unclaimed ORCID profile · follow to get notified of new preprints

Biology Disciplines

Click to filter author papers

Signature Assays, Organisms & Methods

Click to filter · or open tag

Assay:bulk RNA-seq· 2 Approach:experimental assay· 2 Research Focus:cancer & tumor microenvironment· 1 Research Focus:cell type annotation· 1 Research Focus:cell-cell communication· 1 Research Focus:differential expression· 1 Research Focus:gene regulatory network inference· 1 Organism:human· 1

Frequent Co-Authors

Terence E. HébertiD· 2 shared Ashika Jain· 1 shared Bhavneet BhinderiD· 1 shared Caleb Kutz· 1 shared CheukMan Cherie AuiD· 1 shared Darlaine PétriniD· 1 shared Ingrid TorregrozaiD· 1 shared Jason C. TannyiD· 1 shared

Activity by Year

2024-2025 · peak 1/yr

Co-Author Collaboration Network

10 top collaborators · 27 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

2 shared papersMolecular Biology

Terence E. HébertORCID

Mutual co-authors in cluster

Author profile →

2 papers

Recent·Most cited

Molecular BiologyInternational Journal of Molecular SciencesPeer-reviewedSep 12, 2025

Gαq-stimulated gene expression is insensitive to Bromo extra terminal domain inhibitors in HEK 293 cells

Ashika Jain, Viviane Pagé, Dominic Devost…·Jason C. Tanny

The paper tests BET protein responsiveness to G protein isoforms in HEK 293 cells and finds Gq-induced gene expression is insensitive to BET inhibitors, while Gs-induced expression is sensitive to BET degradation.

DOI 10.3390/ijms26188904

humanbulk RNA-seq

𝕏 PostBluesky

Cancer BiologybioRxivPreprintJul 22, 2024

The Orphan G Protein-Coupled Receptor GPR52 is a Novel Regulator of Breast Cancer Multicellular Organization

Sarah Z. Hanif, CheukMan Cherie Au, Ingrid Torregroza…·Kristy A. Brown

This study shows that loss of GPR52 in breast cancer cells increases cell clustering, EMT features, and tumor burden in zebrafish, suggesting GPR52 as a potential therapeutic target.

DOI 10.1101/2024.07.22.604482

zebrafishbulk RNA-seq

𝕏 PostBluesky